D
Centessa Pharmaceuticals plc CNTA
$17.29 $0.291.71% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- 15.00M -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- 15.00M -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- 15.00M -- -- --
SG&A Expenses 11.91M 12.33M 13.71M 12.50M 11.17M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 54.65M 45.78M 74.58M 46.41M 43.98M
Operating Income -54.65M -30.78M -74.58M -46.41M -43.98M
Income Before Tax -49.57M -24.74M -110.28M -41.96M -43.11M
Income Tax Expenses 778.00K 1.40M 1.05M 608.00K 705.00K
Earnings from Continuing Operations -50.34M -26.14M -111.33M -42.57M -43.82M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -50.34M -26.14M -111.33M -42.57M -43.82M
EBIT -54.65M -30.78M -74.58M -46.41M -43.98M
EBITDA -54.43M -30.56M -74.49M -46.32M -43.74M
EPS Basic -0.38 -0.20 -0.84 -0.37 -0.40
Normalized Basic EPS -0.23 -0.12 -0.36 -0.23 -0.25
EPS Diluted -0.38 -0.20 -0.84 -0.37 -0.40
Normalized Diluted EPS -0.23 -0.12 -0.36 -0.23 -0.25
Average Basic Shares Outstanding 133.68M 133.03M 132.05M 116.25M 109.49M
Average Diluted Shares Outstanding 133.68M 133.03M 132.05M 116.25M 109.49M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --